27/06/2022
Published by Fondazione Gianni Bonadonna at 27/06/2022
Categories

Activity of olaparib in patients with BRCA-mutated early breast cancer

Do you like it?0
Read more
20/06/2022
Published by Fondazione Gianni Bonadonna at 20/06/2022
Categories

A breakthrough in the treatment of advanced breast cancer

Do you like it?0
Read more
13/06/2022
Published by Fondazione Gianni Bonadonna at 13/06/2022
Categories

First positive results with a CAR-T therapy plus pembrolizumab in malignant pleural mesothelioma

Do you like it?0
Read more
06/06/2022
Published by Fondazione Gianni Bonadonna at 06/06/2022
Categories

Breast cancer regression with a trispecific antibody

Do you like it?0
Read more
30/05/2022
Published by Fondazione Gianni Bonadonna at 30/05/2022
Categories

Promising results with alpesilib plus olaparib in advanced triple-negative breast cancer

Do you like it?0
Read more
23/05/2022
Published by Fondazione Gianni Bonadonna at 23/05/2022
Categories

Promising antitumor activity of rucaparib and sacituzumab govitecan

Do you like it?0
Read more
16/05/2022
Published by Fondazione Gianni Bonadonna at 16/05/2022
Categories

Safety and activity of the selective FGFR 1-3 inhibitor pemigatinib

Do you like it?0
Read more
09/05/2022
Published by Fondazione Gianni Bonadonna at 09/05/2022
Categories

Breast tumor microenvironment structures are associated with clinical outcomes

Do you like it?0
Read more
02/05/2022
Published by Fondazione Gianni Bonadonna at 02/05/2022
Categories

A new screening platform to discover novel KRAS inhibitors

Do you like it?0
Read more
1234567
Next page
English